Artificial intelligence in colorectal cancer screening
- PMID: 36343958
- PMCID: PMC9828996
- DOI: 10.1503/cmaj.220034
Artificial intelligence in colorectal cancer screening
Conflict of interest statement
Competing interests: Michael Byrne is the chief executive officer, founder and shareholder of Satisfai Health and founder of the AI4GI joint venture (which has a co-development agreement with Olympus America in artificial intelligence and colorectal polyps). Michael Byrne also reports participation in committees with the World Endoscopy Organization and the American Gastroenterological Association Tech Summit. No other competing interests were declared.
Figures
References
-
- Leddin D, Lieberman DA, Tse F, et al. . Clinical practice guideline on screening for colorectal cancer in individuals with a family history of nonhereditary colorectal cancer or adenoma: the Canadian Association of Gastroenterology Banff Consensus. Gastroenterology 2018;155:1325–1347.e3. - PubMed
-
- Aguilera-Chuchuca MJ, Sánchez-Luna SA, González Suárez B, et al. . The emerging role of artificial intelligence in gastrointestinal endoscopy: a review. Gastroenterol Hepatol 2022;45:492–7. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical